Allogene Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.07

-0.15 (-6.76%)

As of Mar 22, 10:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 86%

Hold 2 10%

Sell 1 5%

Price Target

Analyst Price Target +963.3% upside

Low Target $17.29

Average Target $22.01

High Target $30.07

Current Price $2.07

Current
$2.07

Target
$22.01

$17.29 $22.01 avg $30.07

Scenario Analysis

Bear Case

$17.29

735.3%

Low target

Base Case

$22.01

+963.3%

Avg target

Bull Case

$30.07

+1,352.7%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.80

-26.1% from high

52-Week Low

$0.86

+140.1% from low

Target vs 52W High

$22.01

+686.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%